Drug industry vendor Kalderos is urging leaders in Washington to temporarily shield hospitals from losing their 340B eligibility during the COVID-19 pandemic.
“Kalderos is urging a rapid federal response to protect these hospitals,” the company said in a July 23 article on its website.
Drug industry vendor Kalderos is urging leaders in Washington to temporarily shield hospitals from losing their 340B eligibility during the COVID-19 pandemic.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.